Answers are grounded in this paper and cite their sources.
Introduction Abnormalities in neurotransmitter systems, cell signaling, mitochondrial function, oxidative stress, and white matter connectivity have been found to contribute to risk of development of bipolar disorders (BD). In this case-control study, we tested association between diagnosis of BD and gene expression of reelin, the reelin receptor [very low-density lipoprotein receptor (VLDLR)], methylation genes DNMT1, DNMT3A, and demethylation genes TET 1 and TET3, brain-derived neurotrophic factor (BDNF), inflammatory cytokines IL-6 and IL-1β and the glucocorticoid receptor gene NR3C1. Methods Twenty individuals diagnosed with subsyndromal BD and 18 healthy controls (HC) participated in the study. Symptom severity was measured by clinician-administered scales. mRNA was measured quantitatively in peripheral blood mononuclear cells (PBMCs) isolated from whole blood drawn at the time of symptom assessment. Statistical analyses used analysis of variance (ANOVA) and partial Spearman correlations controlling for assay set to measure association. Results There were no significant differences in mRNA values between BD and HC, though higher levels of IL-6 were detected in BD when BMI and age were included in the model. However, significant correlations were detected between low mRNA values and higher levels of depressive symptom severity (VLDLR, TET3, IL-6) and manic symptom severity (TET3, IL-6, NR3C1) in the BD group. None of these correlations survived FDR protected significance levels for 27 correlations, which may be due to small sample size. The findings may support associations between subsyndromal manic and depressive symptoms and reelin receptor VLDLR, demethylation gene TET3, cytokines IL-6 and IL-1B, and glucocorticoid receptor NR3C1 linked to abnormal neural growth.
No takes yet. Share an insight, caveat, or question.
Saunders et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: